Burkehill Global Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-50,000
Closed -$4.87M – 147
2026
Q2
$4.87M Hold
50,000
– – 0.18% 80
2026
Q1
$4.2M Buy
+50,000
New +$2.9M 0.21% 83

Other funds holding DNTH

Burkehill Global Management's DNTH Position: Q3 2026 in Review

Burkehill Global Management sold out of Dianthus Therapeutics (DNTH) in Q3 2026, closing a stake of 50,000 shares — an estimated $4.87M sold.

Burkehill Global Management first reported a position in DNTH in Q1 2026 and held it in 2 quarters. The position peaked at $4.87M in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Burkehill Global Management reported no remaining Dianthus Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Burkehill Global Management sold 50,000 Dianthus Therapeutics shares in Q3 2026, an estimated $4.87M.
  • Burkehill Global Management first reported a position in Dianthus Therapeutics in Q1 2026 and held it in 2 quarters.
  • Burkehill Global Management's Dianthus Therapeutics position peaked at $4.87M in Q2 2026.
  • 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Burkehill Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.